Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.AMEH · Entity 4538 | Director | August 17, 2018 | August 24, 2018 |
| Scienture Holdings, Inc.TRXD · Entity 7802 | Director | October 09, 2019 | October 21, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date August 17, 2018 · Filed August 24, 2018 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 152,997 |
Reported balance
After 2018-08-17 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-08-17 · Sale · Disposed 12,948 · Balance 152,997 |
Scienture Holdings, Inc.
Report date October 09, 2019 · Filed October 21, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,422 |
Reported balance
Holding disclosure · report date 2019-10-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 34,422 |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,000,000 |
Reported balance
Holding disclosure · report date 2019-10-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,000,000 F1: Held by Bedford Falls Capital LLC, an entity which Mr. Augusta controls and serves as President of, and which shares he is deemed to beneficially own. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2024-08-28 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2019-10-09 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: Held by Flacane Advisors Inc., an entity which Mr. Augusta controls, and which securities he is deemed to beneficially own. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2024-08-28 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2019-10-09 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F2: Held by Flacane Advisors Inc., an entity which Mr. Augusta controls, and which securities he is deemed to beneficially own. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by Bedford Falls Capital LLC, an entity which Mr. Augusta controls and serves as President of, and which shares he is deemed to beneficially own.
F2: Held by Flacane Advisors Inc., an entity which Mr. Augusta controls, and which securities he is deemed to beneficially own.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2018 Filed Aug 22, 2018 23:07 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 12,948 | $18.71 | $242,218.24 |
DisclosureSEC source: 0001567619-18-001678 · doc1.xml · nonDerivative · entry 1 Augusta Gary · CIK 0001574651 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,997 Read SEC document |
| August 17, 2018 Filed Aug 24, 2018 17:50 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 12,948 | $18.71 | $242,218.24 |
DisclosureSEC source: 0001567619-18-001764 · doc1.xml · nonDerivative · entry 1 Augusta Gary · CIK 0001574651 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,997 Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 17:47 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001498865-17-000006 · primary_doc.xml · derivative · entry 1 Augusta Gary · CIK 0001574651 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:32 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 93,500 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000006 · primary_doc.xml · derivative · entry 1 Augusta Gary · CIK 0001574651 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vested as to two-thirds of the shares on February 15, 2016 and the balance vests at the rate of one-twelfth per month commencing March 15, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.